Abbott Laboratories (ABT)

50.83
0.03 0.06
NYSE : Health Care
Prev Close 50.80
Open 50.97
Day Low/High 50.62 / 51.00
52 Wk Low/High 37.38 / 51.13
Volume 5.69M
Avg Volume 6.39M
Exchange NYSE
Shares Outstanding 1.74B
Market Cap 88.15B
EPS 0.90
P/E Ratio 57.08
Div & Yield 1.06 (2.10%)

Latest News

Cutting Back on Snap-On

We'll sell over half our SNA position after digesting yesterday's results.

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Stocks Are Guilty by Association: Cramer's 'Mad Money' Recap (Thursday 7/20/17)

Jim Cramer says these market rotations are crushing good stocks that don't deserve it.

Cramer: Rotations Hit Companies That Don't Deserve It

Cramer: Rotations Hit Companies That Don't Deserve It

Case in point: Home Depot and Lowe's.

Dow Trades Lower as Home Depot Tumbles, Consumer Names Rise

Dow Trades Lower as Home Depot Tumbles, Consumer Names Rise

Stocks trade mixed.

We're Downgrading Snap-On

Despite earnings beat, company is in a 'battleground.'

Abbott Labs Reports Strong Quarter

Stock remains a strong performer in our portfolio.

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.

Stocks in Flux as Materials Slump, Consumer Names Trade Higher

Stocks in Flux as Materials Slump, Consumer Names Trade Higher

Stocks are in flux.

Wall Street Sets Up for More Records as T-Mobile Rises, Qualcomm Falls

Wall Street Sets Up for More Records as T-Mobile Rises, Qualcomm Falls

Stock futures are higher.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures are higher on Thursday.

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR

Quidel Diversifies With Alere's Triage Assets

Quidel Diversifies With Alere's Triage Assets

The Triage assets are being divested in order to secure antitrust approvals for Abbott Laboratories' purchase of Alere.

Earnings Previews: 7 Names to Report This Week

What we'll be looking for from ABT, NUE, DHR, KEY, SNA, GE and SLB.

Netflix, Microsoft Better Blow Everyone Away With Their Earnings This Week, Or Else

Netflix, Microsoft Better Blow Everyone Away With Their Earnings This Week, Or Else

The second-quarter earnings season picks up speed.

Weekly Roundup

The market surged this week as positive earnings and a mellower tone from Janet Yellen cheered bulls.

Abbott Laboratories Is Set for Another Breakout

Abbott Laboratories Is Set for Another Breakout

Look to buy at the current market level.

Update on Abbott, TJX and Nucor

A deep dive into 3 of the 10 stocks we highlighted during yesterday's members-only call.

Abbott And Bigfoot Biomedical Announce Collaboration To Develop Breakthrough Diabetes Technologies

Abbott And Bigfoot Biomedical Announce Collaboration To Develop Breakthrough Diabetes Technologies

- AGREEMENT PROMISES MAJOR LEAP FORWARD IN AUTOMATION OF DIABETES MANAGEMENT

Summer Watch List: How Some Key Names Are Stacking Up

Here's what to focus on from these stocks in July.

Weekly Roundup

Jobs report and Fed minutes highlight a short week. In the portfolio, we add one name and downgrade another.

Alere Shareholders Vote to Approve Amended Merger with Abbott

Alere Shareholders Vote to Approve Amended Merger with Abbott

The final vote results will be filed on a Form 8-K with the Securities and Exchange Commission.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ABT, BH, CUBN, PYPL, REIS Downgrades: FRED, FSBC, TDOC Initiations: BBU, CLSD Read on to get TheStreet Quant Ratings' detailed report:

Weekly Roundup

We held back on any big portfolio moves as the quarter ended with bank stress test results and merger news.

Abbott Secures Health Canada License For FreeStyle® Libre System For People With Diabetes

Abbott Secures Health Canada License For FreeStyle® Libre System For People With Diabetes

- REVOLUTIONARY SYSTEM ELIMINATES THE NEED FOR ROUTINE FINGER STICKS1 AND FINGER STICK CALIBRATION

Anadarko, Abbott Labs Are Buys Before They Soar Double Digits -- Analysts

Anadarko, Abbott Labs Are Buys Before They Soar Double Digits -- Analysts

Anadarko has almost 40% upside. Abbott has 20% upside.